arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

Skye Bioscience, Inc.

SKYE

$0.53 ▲ +0.04 (+8.80%) at close

15 Visible periods

20 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

Skye Bioscience, Inc. faces fundamental challenges. The fundamentals warrant careful consideration of downside risks.

Market Cap $21.0M

Dividend Yield —

Revenue Growth —

Op. Margin —

ROIC -290.5% ↘

FCF / Share $-1.09 ↘

Trailing P/E —

Price / Book 0.9x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 7, 2026.

15-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Net Income Profit after all expenses

$-55.92M

↓ -110.5% —

FCF / Share Free cash flow per share

$-1.09

↓ -47.6% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns

Cash Quality →

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Oct 31, 2013 10-K ↗	FY 2012 Oct 31, 2012 10-K ↗	FY 2011 Oct 31, 2011 10-K ↗
EPS Growth YoY (%)	-93.2% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	86.4% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-13325.0% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-100.0% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	33.3% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	N/M	N/M	-45.5% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	35.3% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—
Net Income Growth YoY (%)	-110.5% Weak ↓ Weak Declining Year-over-year change in net income	29.4% Excellent ↑ Excellent Improving Year-over-year change in net income	-93.2% Weak ↓ Weak Declining Year-over-year change in net income	-128.6% Weak Weak Year-over-year change in net income	-29.9% Weak Weak Year-over-year change in net income	N/M	N/M	-520.3% Weak ↓ Weak Declining Year-over-year change in net income	2.6% Caution ↑ Caution Improving Year-over-year change in net income	34.4% Excellent ↑ Excellent Improving Year-over-year change in net income	-77.1% Weak Weak Year-over-year change in net income	-72194.2% Weak Weak Year-over-year change in net income	N/M	—	—
FCF Growth YoY (%)	-47.6% Weak ↑ Weak Improving Year-over-year change in free cash flow	63.1% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	-8565.6% Weak ↓ Weak Declining Year-over-year change in free cash flow	-42.4% Weak ↓ Weak Declining Year-over-year change in free cash flow	38.5% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	41.1% Excellent Excellent Year-over-year change in free cash flow	-36.9% Weak Weak Year-over-year change in free cash flow	—	—	—	—	—	—	—	—

💰 Are margins durable? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Oct 31, 2013 10-K ↗	FY 2012 Oct 31, 2012 10-K ↗	FY 2011 Oct 31, 2011 10-K ↗
Effective Tax Rate (%) (%)	-0.0% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.0% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	-0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.1% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	5.2% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—
FCF / Net Income (x)	0.77x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	1.01x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.37x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.66x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.77x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.92x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	-5.73x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.21x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	—	—	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Oct 31, 2013 10-K ↗	FY 2012 Oct 31, 2012 10-K ↗	FY 2011 Oct 31, 2011 10-K ↗
Return on Invested Capital (%)	-290.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-44.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	1629.5% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	609.0% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-133.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-1395.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-956.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	23.8% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	85.4% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	121.2% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	484.0% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	602.8% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-6.9% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	10.1% Good Good Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-205.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-41.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-290.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-201.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-79.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-235.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-332.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-239.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-692.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-1382.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-123.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-784.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-5.0% Weak Weak Operating profit relative to total assets Optimal: > 10%	9.6% Fair Fair Operating profit relative to total assets Optimal: > 10%	—
Return on Common Equity (%) (%)	-279.3% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1962%)	-39.0% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-360%)	—	—	-145.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1069%)	—	191.9% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+1179%)	123.3% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+722%)	86.7% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+478%)	109.1% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+627%)	—	—	-4.5% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-130%)	11.7% Fair Fair Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-22%)	—

⚖️ Is the balance sheet risky? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Oct 31, 2013 10-K ↗	FY 2012 Oct 31, 2012 10-K ↗	FY 2011 Oct 31, 2011 10-K ↗
Interest Coverage (x)	—	-40.29x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-38.33x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-27.53x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-10.20x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-8.90x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-6.63x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-49.52x Weak Weak Operating income divided by interest expense Optimal: > 5x	-5785.95x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	-3.37x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—
Net Debt (USD)	$-5.88M	$-68.42M	$-1.26M	—	—	—	—	—	$-259.95K	$-64.82K	$-3.22M	$-1.03M	$-52.19K	$-26.40K	$-13.91K

📊 What does each share earn? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Oct 31, 2013 10-K ↗	FY 2012 Oct 31, 2012 10-K ↗	FY 2011 Oct 31, 2011 10-K ↗
Basic EPS, GAAP (USD)	$-1.41	$-0.73	$-5.37	$-0.04	$-0.02	$-0.03	$0.01	$-0.16	$-0.11	$-0.17	—	—	—	—	—
Free Cash Flow per Share (USD)	$-1.09	$-0.74	$-1.99	$-0.02	$-0.02	$-0.03	$-0.04	$-0.03	—	—	—	—	—	—	—
Book Value per Share (USD)	$0.60	$2.20	$-0.17	$-0.00	$0.01	$0.00	$0.00	$-0.12	$-0.11	$-0.14	$-0.04	$-0.03	$0.02	$0.02	—
Tangible Book Value per Share (USD)	$0.60	$2.20	$-0.17	$-0.00	$0.01	$0.00	$0.00	$-0.12	$-0.11	$-0.14	$-0.04	$-0.03	$0.02	$0.02	—
Basic Weighted Avg Shares (shares)	39.66M	36.49M	7.01M	555.27M	406.60M	230.75M	135.15M	121.15M	27.91M	18.95M	—	—	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Oct 31, 2013 10-K ↗	FY 2012 Oct 31, 2012 10-K ↗	FY 2011 Oct 31, 2011 10-K ↗
Working Capital (USD)	$18.89M	$66.49M	$-2.25M	$-3.18M	$5.70M	$1.88M	$1.02M	$-13.99M	$-250.16K	$-382.47K	$2.87M	$-492.69K	$43.82K	$34.02K	—
Total Equity (USD)	$20.02M	$68.15M	$-2.13M	$-3.01M	$5.86M	$450.79K	$548.06K	$-15.56M	$-3.57M	$-2.91M	$-892.20K	$-453.55K	$83.38K	$38.56K	$25.95K

📋 What is driving earnings? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Oct 31, 2013 10-K ↗	FY 2012 Oct 31, 2012 10-K ↗	FY 2011 Oct 31, 2011 10-K ↗
Depreciation Expense (USD)	$723.35K	$298.64K	$124.25K	$115.00K	$34.13K	$1.87K	$1.46K	$1.54K	$8.04K	$14.92K	$9.95K	$1.91K	$10.87K	—	—
Net Income, GAAP (USD)	$-55.92M	$-26.57M	$-37.64M	$-19.48M	$-8.52M	$-6.56M	$1.05M	$-19.19M	$-3.09M	$-3.18M	$-4.84M	$-2.73M	$-3.78K	$4.51K	—
Operating Cash Flow (USD)	$-43.06M	$-25.24M	$-13.95M	$-12.74M	$-6.47M	$-6.05M	$-6.03M	$-3.94M	—	—	—	—	—	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 15 years · 60 quarters

Skye Bioscience, Inc.

Analytical Summary

15-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare SKYE with peers